Literature DB >> 17298462

Nasal polyps and the severity of asthma.

Erkan Ceylan1, Mehmet Gencer, Imran San.   

Abstract

BACKGROUND AND OBJECTIVES: Upper airway pathologies often accompany asthma. Because this represents a single airway, the diagnosis, follow up and treatment of both upper and lower respiratory diseases is essential. Samter Syndrome (SS) is known to be associated with more severe asthma. The presence of nasal polyps (NPs) is also associated with asthma. However, the incidence of NPs in asthma and the effect of NPs on asthma severity are not well documented.
METHODS: Three hundred and forty-two asthma patients were evaluated by endoscopic nasal examination, pulmonary function test, skin prick tests and paranasal sinus tomography.
RESULTS: Three hundred and eleven patients with asthma without NP, 19 asthma patients with NP and 12 patients with SS were included. It was found that 54.3% of patients without NPs, 63.2% with NP and 66.7% with SS were at step 3 on the Global Initiative for Asthma scale of severity, and 1.9%, 15.8% and 33.3% were at step 4, respectively.
CONCLUSIONS: The presence of NPs in asthma patients is associated with an increase in asthma severity. In patients with asthma, the possibility of NPs should be investigated and treatment planned accordingly.

Entities:  

Mesh:

Year:  2007        PMID: 17298462     DOI: 10.1111/j.1440-1843.2006.00964.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  10 in total

1.  Rhinosinusitis and asthma: a link for asthma severity.

Authors:  C Bachert; S E M Claeys; P Tomassen; T van Zele; N Zhang
Journal:  Curr Allergy Asthma Rep       Date:  2010-05       Impact factor: 4.806

2.  Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.

Authors:  Mark C Liu; Bradley Chipps; Xavier Munoz; Gilles Devouassoux; Miguel Bergna; Steven G Smith; Robert G Price; Dmitry V Galkin; Jay Azmi; Dalal Mouneimne; Frank C Albers; Kenneth R Chapman
Journal:  Respir Res       Date:  2021-05-10

Review 3.  Difficult-to-control asthma management through the use of a specific protocol.

Authors:  Pedro Giavina-Bianchi; Marcelo Vivolo Aun; Carla Bisaccioni; Rosana Agondi; Jorge Kalil
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Recommendation for optimal management of severe refractory asthma.

Authors:  Jaymin B Morjaria; Riccardo Polosa
Journal:  J Asthma Allergy       Date:  2010-07-26

5.  Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis.

Authors:  Enrico Heffler; Fabiana Saccheri; Marta Bartezaghi; Giorgio Walter Canonica
Journal:  Clin Transl Allergy       Date:  2020-06-26       Impact factor: 5.871

Review 6.  Impact of comorbid conditions on asthmatic adults and children.

Authors:  Alan Kaplan; Stanley J Szefler; David M G Halpin
Journal:  NPJ Prim Care Respir Med       Date:  2020-08-20       Impact factor: 2.871

7.  Comorbidities are associated with different features of severe asthma.

Authors:  Federica Novelli; Elena Bacci; Manuela Latorre; Veronica Seccia; Maria Laura Bartoli; Silvana Cianchetti; Federico Lorenzo Dente; Antonella Di Franco; Alessandro Celi; Pierluigi Paggiaro
Journal:  Clin Mol Allergy       Date:  2018-12-03

8.  Risk factors for the development of bronchiectasis in patients with asthma.

Authors:  Donghai Ma; María-Jesús Cruz; Iñigo Ojanguren; Christian Romero-Mesones; Diego Varona-Porres; Xavier Munoz
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

Review 9.  Type 2 inflammation in asthma and other airway diseases.

Authors:  Jorge Maspero; Yochai Adir; Mona Al-Ahmad; Carlos A Celis-Preciado; Federico D Colodenco; Pedro Giavina-Bianchi; Hani Lababidi; Olivier Ledanois; Bassam Mahoub; Diahn-Warng Perng; Juan C Vazquez; Arzu Yorgancioglu
Journal:  ERJ Open Res       Date:  2022-08-01

10.  Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis.

Authors:  Carla Bisaccioni; Marcelo Vivolo Aun; Edcarlos Cajuela; Jorge Kalil; Rosana Câmara Agondi; Pedro Giavina-Bianchi
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.